These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Circulating endostatin as a risk factor for cardiovascular events in patients with stable coronary heart disease: A CLARICOR trial sub-study. Ruge T; Carlsson AC; Kjøller E; Hilden J; Kolmos HJ; Sajadieh A; Kastrup J; Jensen GB; Larsson A; Nowak C; Jakobsen JC; Winkel P; Gluud C; Ärnlöv J Atherosclerosis; 2019 May; 284():202-208. PubMed ID: 30959314 [TBL] [Abstract][Full Text] [Related]
11. Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial. Winkel P; Jakobsen JC; Hilden J; Lange T; Jensen GB; Kjøller E; Sajadieh A; Kastrup J; Kolmos HJ; Larsson A; Ärnlöv J; Gluud C Diagn Progn Res; 2017; 1():10. PubMed ID: 31093541 [TBL] [Abstract][Full Text] [Related]
12. The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease. Lafeber M; Spiering W; van der Graaf Y; Nathoe H; Bots ML; Grobbee DE; Visseren FL Am Heart J; 2013 Aug; 166(2):282-289.e1. PubMed ID: 23895811 [TBL] [Abstract][Full Text] [Related]
13. [Intervention with clarithromycin in patients with stable coronary heart disease--the CLARICOR trial: secondary publication]. CLARICOR-Gruppen Ugeskr Laeger; 2007 Feb; 169(6):497-9. PubMed ID: 17303029 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies. Schembri S; Williamson PA; Short PM; Singanayagam A; Akram A; Taylor J; Singanayagam A; Hill AT; Chalmers JD BMJ; 2013 Mar; 346():f1235. PubMed ID: 23525864 [TBL] [Abstract][Full Text] [Related]
15. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study. Fox K; Ferrari R; Tendera M; Steg PG; Ford I; Am Heart J; 2006 Nov; 152(5):860-6. PubMed ID: 17070146 [TBL] [Abstract][Full Text] [Related]
16. Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT trial. Bangalore S; Breazna A; DeMicco DA; Wun CC; Messerli FH; J Am Coll Cardiol; 2015 Apr; 65(15):1539-48. PubMed ID: 25881936 [TBL] [Abstract][Full Text] [Related]
17. Three-year follow-up in a subset of high-risk patients randomly assigned to off-pump versus on-pump coronary artery bypass surgery: the Best Bypass Surgery trial. Møller CH; Perko MJ; Lund JT; Andersen LW; Kelbæk H; Madsen JK; Winkel P; Gluud C; Steinbrüchel DA Heart; 2011 Jun; 97(11):907-13. PubMed ID: 21415073 [TBL] [Abstract][Full Text] [Related]
18. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial. Harutyunyan MJ; Mathiasen AB; Winkel P; Gøtze JP; Hansen JF; Hildebrandt P; Jensen GB; Hilden J; Jespersen CM; Kjøller E; Kolmos HJ; Gluud C; Kastrup J; Scand J Clin Lab Invest; 2011 Feb; 71(1):52-62. PubMed ID: 21108561 [TBL] [Abstract][Full Text] [Related]
19. Clarithromycin use and risk of death in patients with ischemic heart disease. Andersen SS; Hansen ML; Norgaard ML; Folke F; Fosbøl EL; Abildstrøm SZ; Raunsø J; Madsen M; Køber L; Gislason GH; Torp-Pedersen C Cardiology; 2010; 116(2):89-97. PubMed ID: 20523043 [TBL] [Abstract][Full Text] [Related]
20. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Keech A; Simes RJ; Barter P; Best J; Scott R; Taskinen MR; Forder P; Pillai A; Davis T; Glasziou P; Drury P; Kesäniemi YA; Sullivan D; Hunt D; Colman P; d'Emden M; Whiting M; Ehnholm C; Laakso M; Lancet; 2005 Nov; 366(9500):1849-61. PubMed ID: 16310551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]